この研究資金を受けている欧州共同体の第 7 フレームワーク プログラム (FP7/2007-2013) から付与契約番号 305436 の下恒星。

The local medical ethical committee and ethical advisory board of the European consortium (STELLAR) approved the research and collection of human transplant grade kidneys discarded mainly for surgical reasons. Research consent was given for all kidneys.
1. Preparations for Cell Culture
<ol>
	<li>Prepare a pool of platelet lysates.
	<ol>
		<li>Store the platelets that have expired for less than 2 d in -80 &#176;C until use (for a maximum of 1 year). 
		NOTE: The platelets were originally sourced from a commercial vendor. Hospital surplus material distributed by the local blood bank were obtained.</li>
		<li>Thaw the platelets of at least 5 donors (preferably 10) O/N at 4 &#176;C.</li>
		<li>Pool the platelets in a large sterile bottle, transfer to conical centrifuge tubes and spin down for 10 min at 1,960 x g at 4 &#176;C. 
		NOTE: The volume of platelets depends on the number of donors and the amount of hospital surplus material per donor.</li>
		<li>Pipette the supernatant to blood bags (50 mL/bag) through the barrel of a 50 mL syringe. Store at -80 &#176;C.</li>
	</ol>
	</li>
	<li>Preparation of cell culture medium.
	<ol>
		<li>Defrost one bag of platelet lysates in a water bath at 37 &#176;C.</li>
		<li>Add 1 L (i.e. 2 bottles) of Minimum Essential Medium - alpha modification (alphaMEM), 5 mL 200 mM glutamine, and 20 mL of penicillin (5,000 U/mL)/streptomycin (5,000 &#181;g/mL) (pen/strep) to the bag.</li>
		<li>Incubate for 3 h at 37 &#176;C.</li>
		<li>Shake the bag for degelling by gently tapping on the bag when the bag is resting on a flat surface.</li>
		<li>Filter the 5% platelet lysates medium by pulling the lysates through the filter of the transfusion system with a sterile 50 mL syringe.</li>
		<li>Aliquot the medium in 50 mL tubes and store in -80 &#176;C until use. 
		NOTE: Every new batch of platelet lysates is tested in cell culture and compared to the previous batch by growing cells of interest (bmMSCs or kPSCs) to confluency in both batches. In cell numbers and viability, the kPSCs or bmMCs grown in the new batch should not differ more than 10%, and the marker expression of CD73, CD90, CD105 and CD31, CD34 and CD45 as analyzed by flow cytometry should not differ. The methods of cell culture are described in section 6 of the protocol (Culture of kPSC).</li>
	</ol>
	</li>
</ol>
2. Preparations for Cell Harvest
<ol>
	<li>Preparation of solutions.
	<ol>
		<li>Prepare the plain medium by adding 10 mL of pen/strep to 500 mL (1 bottle) of Dulbecco&#39;s Minimum Essential Medium (DMEM)-F12.</li>
		<li>Prepare the washing medium by adding 50 mL of Normal Human Serum (NHS) and 10 mL of pen/strep to 1 bottle of DMEM-F12.</li>
		<li>Prepare the enzyme-stock buffer by adding 2.9 mL 1 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 1.2 mL NaHCO3 2.5% [w/v] and 160 &#181;L CaCl2 (1 M) to 160 mL University of Wisconsin solution.</li>
		<li>Prepare the collagenase solution by slowly adding 20 mL of enzyme stock buffer to the bottle of GMP-grade collagenase containing &#62;2,000 U/bottle collagenase. Dissolve at 4 &#176;C for approximately 40 min. Gently shake several times during the dissolving period.</li>
		<li>Prepare the freeze medium by adding 5 mL dimethyl sulfoxide (DMSO) to 45 mL NHS.</li>
	</ol>
	</li>
	<li>Preparation of perfusion tray (Figure 1A).
	<ol>
		<li>Clean the flow cabin and cover with surgical drapes. Heat a water bath to approximately 40 - 45 &#176;C to heat the perfusion tray to 37 &#176;C. Put on surgical gowns and surgical gloves.</li>
		<li>Connect a sterilized perfusion tray to the water bath to preheat the perfusion tray with warm water. Make sure that there is no air in the perfusion tray by starting with the perfusion tray in the vertical position. If necessary add more water to the water bath to prevent air infusion into the perfusion tray.</li>
		<li>Place the LS25 tube in the pump. Leave both sterile ends of the tube in the flow cabinet. Place a Kocher&#39;s forceps on one end of the tube and allow to rest on the bottom of the perfusion tray. Place a sterile gauze on top of the tube to prevent obstruction. Attach a Luer connector on the other tube end.</li>
		<li>Add approximately 100 mL of plain medium into the perfusion tray and start flushing the tube on a pump speed of 100 mL/min.</li>
	</ol>
	</li>
</ol>
3. Kidney Cell Isolation
<ol>
	<li>Preparation of the kidney.
	<ol>
		<li>Remove the kidney from the double sterile bags and place on the sterile perfusion tray (Figure 1B). Remove the perirenal adipose tissue and kidney capsule with scissors and gentle tearing (Figure 1C) and identify the renal artery on the aortic patch as shown in Figure 1D.</li>
		<li>Cannulate the renal artery with the accessory spike, fix with a sterilized tie-rip, and attach to the pump tube end with the Luer connector while the pump is on. If the tubes are not completely filled, first add more medium to the tray and flush tubes by starting the pump (Figure 1E - F). Flush the kidney with plain medium via the pump with a flow of 100 mL/min.</li>
	</ol>
	</li>
	<li>Collagenase treatment and kidney cell isolation.
	<ol>
		<li>Add collagenase (20 mL, &#62;2,000 U) and DNase (2.5 mL, 1 mg/mL) to the perfusion tray (Figure 1G). Turn the kidney from time to time gently by hand. Wait until the kidney becomes soft and the perfusion liquid becomes less transparent (approximately 30 - 40 min).</li>
		<li>Gently massage the kidney (Figure 1H) until a cell suspension is obtained (Figure 1I). Remove non-digested material and the spike in the renal artery.</li>
	</ol>
	</li>
	<li>Washing and collection of kidney cells.
	<ol>
		<li>Add 50 mL of the NHS to the cell suspension. Drain the cell suspension from the perfusion tray by putting the pump at low flow and placing the tube first connected to the kidney above the 50 mL tubes (Figure 1J).</li>
		<li>Centrifuge at 300 x g for 7 min at 4 &#730;C and remove the supernatant. Wash the pellets with washing medium containing 10% NHS and again centrifuge at 300 x g for 7 min. Repeat washing once more. Measure the volume of the cell pellets and add an equal volume of cell culture medium.</li>
		<li>Either cryopreserve the cells from here by adding freezing medium 1:1 to the cell suspension and store in cryogenic vials according to standard protocols, or continue to culture the cells (section 4). 
		NOTE: The cell suspension contains cell clumps and requires extra steps to obtain single cells, which results in an increase in cell death. Therefore, the cells are kept in suspension and are not counted at this stage.</li>
	</ol>
	</li>
</ol>
4. Cell Culture of Crude Kidney Cells
<ol>
	<li>Add approximately 1 mL of the cell suspension to 24 mL of alphaMEM 5% platelet lysates (cell culture medium) in a T175 cell culture flask (Figure 1K) and culture at 37 &#176;C, 5% CO2. Remove the medium and cell debris after 2 d&#160;from the adherent cells and refresh the medium with 25 mL of cell culture medium.</li>
	<li>Refresh the culture medium twice a week by removing half of the medium (12.5 mL) and adding fresh medium (12.5 mL) using aseptic techniques.</li>
	<li>Culture until confluent (usually 5 - 7 d) (Figure 1L). Remove the medium, wash twice with PBS and trypsinize the cells by adding 5 mL trypsin to each T175 flask for 5 min at 37 &#176;C. Wash in culture medium and centrifuge at 490 x g for 5 min and remove the supernatant.</li>
</ol>
5. Cell Enrichment for NG2 by Magnetic Cell Separation (Figure 1M)
<ol>
	<li>Prepare the cell separation buffer according to manufacturer&#39;s protocol.</li>
	<li>Resuspend the trypsinized kPSCs in 10 mL cell separation buffer. Centrifuge at 490 x g for 5 min, discard the supernatant and resuspend the cells in 300 &#181;L cell separation buffer.</li>
	<li>Add 100 &#181;L FcR blocking reagen/5 x 107 cells, add 100 &#181;L anti-melanoma (NG2) beads per 5 x 107 cells, and incubate for 30 min at 4 &#176;C. Separate the NG2-positive fraction according to manufacturer&#39;s protocol. Add 10 mL of medium and centrifuge cells for 5 min at 490 x g.</li>
	<li>Count the cells using a B&#252;rker counting chamber according to manufacturer&#39;s protocol. Seed the cells in a culture flask (approximately 4 x 103 cells/cm2) and incubate. 
	NOTE: Seed the cells in the following concentrations: &#60;250,000 in a T25 flask, 250,000 - 500,000 in a T75 flask, and 700,000 - 800,000 in a T175 flask. After magnetic cell enrichment, a positive fraction of approximately 1 - 2% is isolated. However, as this step is cell enrichment and not cell sorting, other cell types will be present in the culture (Figure 1N). After several passages (usually around 4 - 5), only a homogenous kPSC-population is present (Figure 1P).</li>
</ol>
6. Culture of kPSCs
<ol>
	<li>Refresh the medium twice a week by removing half of the medium and replace it with freshly thawed culture medium (Figure 1N). 
	NOTE: The kPSCs tend to be more viable and proliferative when only half of the medium is refreshed.</li>
	<li>Passaging of kPSCs. 
	NOTE: Passage the kPSCs at either 90 - 100% confluency, or when 3D structures appear (see Figure 1O), or when there hasn&#39;t been cell growth for more than a week. The latter two particularly might occur at early passages after cell enrichment. In this case, after passaging, the cells will usually start to grow again in monolayer culture (Figure 1P).
	<ol>
		<li>Remove the medium from the 90 - 100% confluent cells (keep the medium for later use). Wash the flask twice with PBS (1 mL in T25, 5 mL in T75, 10 mL in T175). Add trypsin (0.5 mL in T25, 2 mL in T75, 5 mL in T175) and incubate for 5 min at 37 &#176;C. Add the old medium to the flask and resuspend gently.</li>
		<li>Transfer to a 15&#160;or 50 mL tube (depending on the volume) and centrifuge at 490 x g for 5 min. Count the viable cells and plate &#60;250,000 in a T25, 250,000 - 500,000 in a T75, or 700,000 - 800,000 in a T175 (approximately 4 x 103 cells/cm2).</li>
	</ol>
	</li>
	<li>Test the kPSCs at passage 5 or 6 (e.g., scratch assay, section 7). 
	NOTE: Characterize the propagated cells by flow cytometry using standard protocols. Marker expression of NG2, PDGFR-&#946;, CD146, CD73, CD90, CD105, HLA-ABC should all be positive and CD31, CD34, CD45 and HLA-DR should be negative. Test for mycoplasma, bacteria and fungi in the culture medium according to standard protocols of the clinical microbiology lab. Test the kPSCs functionally in a kidney epithelial wound scratch assay. Experiments are usually performed with sterile, flow cytometry-confirmed homogeneous kPSC populations with wound healing capacity between passage 6-8.</li>
	<li>Cryopreserve the kPSCs by adding 0.5 mL cryopreservation medium to 0.5 mL cell suspension (2 million cells per mL of culture medium) using standard protocols. 
	NOTE: After thawing, seed the kPSCs at a higher density (106&#160;cells in a T175).</li>
</ol>
7. Functional Test of kPSCs: Kidney Epithelial Wound Scratch Assay
<ol>
	<li>Culture the kPSCs in a 6-well plate at a density of 200,000 cells/well in 2 mL culture medium. After 48 h of culture at 37 &#176;C, 5% CO2, collect the supernatant. This is the conditioned medium.</li>
	<li>Seed the HK-2 (proximal tubular epithelial cells)17 in 2 mL of Proximal Tubular Epithelial Cell (PTEC) medium consisting of a 1:1 ratio of DMEM-F12 supplemented with insulin (5 mg/mL), transferrin (5 mg/mL), selenium (5 ng/mL), hydrocortisone (36 ng/mL), triiodothyrinine (40 pg/mL), epidermal growth factor (10 ng/mL) and pen/strep, in a density of 500,000 cells per well in a 6-well cell culture plate.</li>
	<li>Culture for 48 h at 37 &#176;C, 5% CO2. Remove the cell culture medium of the HK-2s and create a scratch wound in the monolayer of HK-2s by making a scratch with the tip of a yellow pipette point from the top to the bottom of the well. Wash the HK-2s with PBS and add the conditioned medium of the kPSCs or control medium. Mark on the bottom of the plate the area to be imaged. 
	NOTE: The HK-2s should be confluent. Image two areas per well.</li>
	<li>Image the scratch at 4, 8, 12 and 24 h at the same marked position with an inverted bright-field microscope.</li>
	<li>Measure the scratch area in Image J using the polygon selection tool to determine the percentage of closure.</li>
</ol>

<ol>
	<li>Friedenstein, A. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Precursors+for+fibroblasts+in+different+populations+of+hematopoietic+cells+as+detected+by+the+in+vitro+colony+assay+method.">Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method.</a> Exp Hematol. 2 (2), 83-92 (1974).</li><li>Dominici, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Minimal+criteria+for+defining+multipotent+mesenchymal+stromal+cells.+The+International+Society+for+Cellular+Therapy+position+statement.">Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.</a> Cytotherapy. 8 (4), 315-317 (2006).</li><li>Pittenger, M. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Multilineage+potential+of+adult+human+mesenchymal+stem+cells.">Multilineage potential of adult human mesenchymal stem cells.</a> Science. 284 (5411), 143-147 (1999).</li><li>Leuning, D. G., Reinders, M. E., de Fijter, J. W., Rabelink, T. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Clinical+translation+of+multipotent+mesenchymal+stromal+cells+in+transplantation.">Clinical translation of multipotent mesenchymal stromal cells in transplantation.</a> Semin Nephrol. 34 (4), 351-364 (2014).</li><li>Reinders, M. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Autologous+bone+marrow-derived+mesenchymal+stromal+cells+for+the+treatment+of+allograft+rejection+after+renal+transplantation:+results+of+a+phase+I+study.">Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.</a> Stem Cells Transl Med. 2 (2), 107-111 (2013).</li><li>Perico, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Autologous+mesenchymal+stromal+cells+and+kidney+transplantation:+a+pilot+study+of+safety+and+clinical+feasibility.">Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.</a> Clin J Am Soc Nephrol. 6 (2), 412-422 (2011).</li><li>Perico, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mesenchymal+stromal+cells+and+kidney+transplantation:+pretransplant+infusion+protects+from+graft+dysfunction+while+fostering+immunoregulation.">Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.</a> Transpl Int. 26 (9), 867-878 (2013).</li><li>Tan, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Induction+therapy+with+autologous+mesenchymal+stem+cells+in+living-related+kidney+transplants:+a+randomized+controlled+trial.">Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.</a> JAMA. 307 (11), 1169-1177 (2012).</li><li>Crisan, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+perivascular+origin+for+mesenchymal+stem+cells+in+multiple+human+organs.">A perivascular origin for mesenchymal stem cells in multiple human organs.</a> Cell Stem Cell. 3 (3), 301-313 (2008).</li><li>Sacchetti, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=No+Identical+"Mesenchymal+Stem+Cells"+at+Different+Times+and+Sites:+Human+Committed+Progenitors+of+Distinct+Origin+and+Differentiation+Potential+Are+Incorporated+as+Adventitial+Cells+in+Microvessels.">No Identical "Mesenchymal Stem Cells" at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels.</a> Stem Cell Reports. 6 (6), 897-913 (2016).</li><li>Chen, W. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+myocardial+pericytes:+multipotent+mesodermal+precursors+exhibiting+cardiac+specificity.">Human myocardial pericytes: multipotent mesodermal precursors exhibiting cardiac specificity.</a> Stem Cells. 33 (2), 557-573 (2015).</li><li>Dekel, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Isolation+and+characterization+of+nontubular+sca-1+lin-+multipotent+stem/progenitor+cells+from+adult+mouse+kidney.">Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney.</a> J Am Soc Nephrol. 17 (12), 3300-3314 (2006).</li><li>Li, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Collecting+duct-derived+cells+display+mesenchymal+stem+cell+properties+and+retain+selective+in+vitro+and+in+vivo+epithelial+capacity.">Collecting duct-derived cells display mesenchymal stem cell properties and retain selective in vitro and in vivo epithelial capacity.</a> J Am Soc Nephrol. 26 (1), 81-94 (2015).</li><li>Pelekanos, R. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Comprehensive+transcriptome+and+immunophenotype+analysis+of+renal+and+cardiac+MSC-like+populations+supports+strong+congruence+with+bone+marrow+MSC+despite+maintenance+of+distinct+identities.">Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities.</a> Stem Cell Res. 8 (1), 58-73 (2012).</li><li>Leuning, D. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Clinical-Grade+Isolated+Human+Kidney+Perivascular+Stromal+Cells+as+an+Organotypic+Cell+Source+for+Kidney+Regenerative+Medicine.">Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine.</a> Stem Cells Transl Med. , (2016).</li><li>Bruno, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Isolation+and+characterization+of+resident+mesenchymal+stem+cells+in+human+glomeruli.">Isolation and characterization of resident mesenchymal stem cells in human glomeruli.</a> Stem Cells Dev. 18 (6), 867-880 (2009).</li><li>Ryan, M. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=HK-2:+an+immortalized+proximal+tubule+epithelial+cell+line+from+normal+adult+human+kidney.">HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney.</a> Kidney Int. 45 (1), 48-57 (1994).</li><li>Nijhoff, M. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Glycemic+Stability+Through+Islet-After-Kidney+Transplantation+Using+an+Alemtuzumab-Based+Induction+Regimen+and+Long-Term+Triple-Maintenance+Immunosuppression.">Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression.</a> Am J Transplant. , (2015).</li></ol>

機械知能系、D.G.L.、T.J.R. は、この研究に関する特許出願に関連付けられます。他の作家が何を開示するあります。

血管周囲細胞は多くの異なった人間固体器官、膵臓、脂肪、軟骨、腎臓9,,1516などから分離されています。ただし、ほとんどのメソッドは、組織を切除し、その後消化酵素で処理の小さなサンプルに基づいています。また、これは通常行われません臨床グレード製品。これにより、臨床グレード細胞の大量が必要これらの戦略を直接臨床翻訳には適して。
ここで臨床グレード酵素および物質による血液灌流に基づく全臓器の人間 kPSCs の新規分離法を示す.プロトコルは、現在臨床応用センター18使用中臨床ランゲルハンス島の隔離のプロトコルから適応。
これは、大量の kPSCs を実現できます最初の臨床グレード方法です。細胞収率の変動は主としてドナー依存です。しかし、我々 は現在 3 つの異なるドナー原油細胞懸濁液の一部から得る細胞収量を推定すると、理論的には、ドナーごと 1012 kPSCs x 2.7 の平均利回りが達成できます。MSC 療法は、通常、1 - 2 × 106セル/kg 本体重量42 細胞注入で構成されますとこれらの細胞の数はいくつかの患者の同種の治療のため十分です。
分離のプロシージャの 1 つの重要なステップは、コラゲナーゼの消化力の期間です。消化期間が短すぎると、文化が困難となる、組織の大きな塊保たれます。潅流期間が長すぎると、細胞死が増加を観察することがあります。したがって、腎臓ソフトになり、流体透過性が低下し始めると、すぐに腎臓を優しくマッサージする必要があります、コラゲナーゼ処理を停止する必要があります。
別の重要なステップは、NG2 細胞濃縮後、細胞の培養です。NG2 細胞濃縮後時々 血管周囲細胞は増殖や立体構造で成長を開始する開始されません。この場合ときに、細胞がトリプシンおよび再シード、細胞が単層培養による成長を開始通常。
出発材料として人間の移植グレード腎臓手術の理由主に破棄されたが使用されました。これらの主要な線維化なし機能器官です。我々 は、これは比較的まれな制限をする可能性がありますこれを認めるとオルガンのソースを取得するは難しい。Explanted 腎臓可能性があります別のソース;しかし、腎植の理由に応じてより多くの線維化およびこうして芽、これらの腎臓があります、したがってケアしなければならないので芽を分離、培養血管細胞ではなく可能性があります。
KPSCs が分離されたこのプロトコルを見ると腎臓上皮とオルガノ typic プロパティ創傷治癒能力15、腎臓疾患における kPSCs を用いた細胞治療、移植は今後の興味深いアプリケーションになります。このため、セル/セル製品出荷のいくつかの戦略があります。BmMSC の臨床試験で現在使われている、最初の戦略は、kPSCs の点滴です。別の興味深いアプリケーションは、kPSCs, 移植前に機械灌流 kPSC 排泄要因の使用です。このように、移植後改善された腎機能につながる可能性があるが explanted 腎臓の質を改善するかもしれない。両方の戦略 kPSCs 臨床目的のためさらに探索する興味深い新しいセル源であります。

間葉系間質細胞 (MSCs) は、もともと骨の髄から分離された免疫の調節細胞です。彼らは彼らの紡錘の形態、脂肪、骨、軟骨、およびプラスチックの付着に分化する能力を形によって特徴付けられます。MSCs は、間質マーカー CD73、CD90、マーカー CD31、CD451,2,3負ながら CD105 を表現します。MSCs は、彼らの組織の恒常性維持と免疫調節能力のための細胞療法の有望な候補です。bmMSCs は、腎臓病と腎移植4として他の場所を含むいくつかの疾患の臨床試験で現在検討中です。
以前血管周囲脂肪組織を含むいくつかの異なった固体器官から細胞、胎盤および骨格筋は MSCs9と特性を共有ことが示されました。しかし、これらの細胞はまた脊髄修復10になることができます組織固有の関数を表わします。ひと心筋血管周囲細胞低酸素後の血管新生反応の刺激など、一方、他の組織から分離した血管周囲細胞はこれらの電位11を表示されませんでした、心筋細胞に分化します。
血管周囲間質細胞は、マウス12,13,14ひと腎臓15,16から分離することができます。我々 の広範囲 kPSCs を特徴し、bmMSCs にこれらを比較します。KPSCs、bmMSCs と同様、免疫能力および血管叢形成をサポートすることができますがわかった。ただし、特定セル型では、腎の転写因子 HoxD10 および HoxD11 を含めて、脊髄転写式署名を示した kPSCs と違い組織があります。kPSCs、bmMSCs と対照をなして TGF-β 刺激後の myofibroblast 変換を受けていないと、脂肪細胞に分化することができませんでした。さらに、kPSCs は、腎尿細管上皮創傷スクラッチ アッセイ、bmMSCs と見られなかった現象で上皮の完全性を加速しました。この強化された傷修理だった肝細胞成長因子の遊離を介する。さらに、kPSCs は、急性腎傷害15マウス モデルにおける腎障害を改善しました。したがって、kPSCs は優れた腎修復能力を持っているようだ、腎臓病の細胞療法のための興味深い新しいソースです。
細胞療法目的で kPSCs を使用するために、kPSCs は臨床グレード酵素とプロトコル臨床グレードの方法で分離する必要があります。また、1 ドナーから kPSCs と数人の患者を治療することには、十分な細胞数を取得必要があります。ここで我々 は臨床細胞療法に使用する細胞の十分な数を降伏詳細、全体移植グレード腎臓から kPSCs の臨床グレードの隔離プロシージャに表示します。

<table><tbody><tr><td>Baxter bags</td><td>Fenwal</td><td>R4R-7004</td><td></td></tr><tr><td>Human platelets</td><td>Sanquin</td><td></td><td>hospital surplus material expired for less than 2 d is used</td></tr><tr><td>platelet lysate</td><td></td><td></td><td>custom made</td></tr><tr><td>Disposable sterile bottles</td><td>Corning</td><td>09-761-11</td><td></td></tr><tr><td>500 mL PP centrifuge tubes</td><td>Corning</td><td>431123</td><td></td></tr><tr><td>a-MEM medium</td><td>Lonza</td><td>BE12-169F</td><td></td></tr><tr><td>glutamax</td><td>thermo fisher</td><td>35050038</td><td></td></tr><tr><td>pen/strep&amp;nbsp;</td><td>Invitrogen</td><td>15070063</td><td></td></tr><tr><td>transfusion system</td><td>Codan</td><td>455609</td><td></td></tr><tr><td>DMEM-F12</td><td>life technologies</td><td>11320-074</td><td></td></tr><tr><td>Normal Human Serum (NHS)</td><td>Sanquin</td><td></td><td></td></tr><tr><td>Hepes 1 M</td><td>Lonza</td><td>BE-17-737E</td><td></td></tr><tr><td>NaHCO&lt;sub&gt;3&lt;/sub&gt; 7.5%</td><td>Lonza</td><td>BE17-613E</td><td></td></tr><tr><td>CaCl&lt;sub&gt;2&lt;/sub&gt; 1 M</td><td>Sigma-Aldrich</td><td>10043-52-4</td><td></td></tr><tr><td>UW</td><td>Bridge to life</td><td>32911</td><td></td></tr><tr><td>Heparin</td><td>Leo Pharma</td><td></td><td></td></tr><tr><td>collagenase NB1 GMP grade</td><td>SERVA</td><td>17455.03</td><td></td></tr><tr><td>DMSO</td><td>Sigma Aldrich</td><td>D2650-100ml</td><td></td></tr><tr><td>surgical drapes</td><td>3M Nederland</td><td>DH999969404</td><td></td></tr><tr><td>perfusion pump</td><td>metrohm</td><td>x007528300</td><td></td></tr><tr><td>pump head</td><td>metrohm</td><td>x077202600</td><td></td></tr><tr><td>perfusion tray</td><td></td><td></td><td>custom made</td></tr><tr><td>LS25 masterflex tubes</td><td>Masterflex</td><td>HV-96410-25</td><td></td></tr><tr><td>accessory spike</td><td>Gambro DASCO</td><td>6038020</td><td></td></tr><tr><td>pulmozyme</td><td>Roche</td><td></td><td></td></tr><tr><td>culture flasks 25 cm&lt;sup&gt;2&lt;/sup&gt;</td><td>greiner</td><td>690175</td><td></td></tr><tr><td>culture flask 75 cm&lt;sup&gt;2&lt;/sup&gt;</td><td>greiner</td><td>658170</td><td></td></tr><tr><td>culture flask 175 cm&lt;sup&gt;2&lt;/sup&gt;</td><td>greiner</td><td>661160</td><td></td></tr><tr><td>Trypsin</td><td>sigma</td><td>t4174</td><td></td></tr><tr><td>Bovine Serum Albumin (BSA)</td><td>Sigma</td><td>A2153</td><td></td></tr><tr><td>EDTA</td><td>Sigma-Aldrich</td><td>E5134-500g</td><td></td></tr><tr><td>FcR blocking reagent</td><td>miltenyi</td><td>130-059-901</td><td></td></tr><tr><td>anti melanoma beads (NG2)</td><td>miltenyi</td><td>130-090-452</td><td></td></tr><tr><td>cell strainer 70 &amp;micro;m</td><td>Corning</td><td>352350</td><td></td></tr><tr><td>LS columns</td><td>Miltenyi</td><td>130-042-401</td><td></td></tr><tr><td>MACS magnet</td><td>miltenyi</td><td>130-090-976</td><td></td></tr><tr><td>CD34 FITC</td><td>BD&amp;nbsp;</td><td>555821</td><td></td></tr><tr><td>CD45 APC</td><td>BD&amp;nbsp;</td><td>555485</td><td></td></tr><tr><td>CD146 PE</td><td>BD&amp;nbsp;</td><td>550315</td><td></td></tr><tr><td>NG2 APC</td><td>R&amp;amp;D</td><td>FAB2585A</td><td></td></tr><tr><td>CD90 PE</td><td>BD&amp;nbsp;</td><td>555596</td><td></td></tr><tr><td>HLA ABC APC</td><td>BD&amp;nbsp;</td><td>555555</td><td></td></tr><tr><td>CD105 FITC</td><td>Ancell</td><td>326-040</td><td></td></tr><tr><td>HLA DR APC</td><td>BD&amp;nbsp;</td><td>559866</td><td></td></tr><tr><td>CD56 PE</td><td>BD&amp;nbsp;</td><td>555516</td><td></td></tr><tr><td>CD73 PE</td><td>BD&amp;nbsp;</td><td>550257</td><td></td></tr><tr><td>CD31 FITC</td><td>BD&amp;nbsp;</td><td>555445</td><td></td></tr><tr><td>CD133 PE</td><td>miltenyi</td><td>130-090-853</td><td></td></tr><tr><td>PDGF-r&amp;nbsp;</td><td>R&amp;amp;D</td><td>mab 1263</td><td></td></tr><tr><td>mouse IgG1 FITC</td><td>BD&amp;nbsp;</td><td>345815</td><td></td></tr><tr><td>mouse IgG1 PE</td><td>BD&amp;nbsp;</td><td>345816</td><td></td></tr><tr><td>mouse IgG1 APC</td><td>BD&amp;nbsp;</td><td>345818</td><td></td></tr><tr><td>IgG2b PE</td><td>BD&amp;nbsp;</td><td>555743</td><td></td></tr><tr><td>goat anti mouse PE</td><td>Dako</td><td>R0480</td><td></td></tr><tr><td>sodium azide</td><td>Merck</td><td>822335</td><td></td></tr><tr><td>DMEM Ham&amp;rsquo;s F12</td><td>Gibco</td><td>31331-028</td><td></td></tr><tr><td>ITS (insulin, transferrin, selenium)</td><td>Sigma</td><td>I1884</td><td></td></tr><tr><td>hydrocortisone</td><td>Sigma</td><td>H0135</td><td></td></tr><tr><td>triiodothyrinine</td><td>Sigma</td><td>T5516</td><td></td></tr><tr><td>Epidermal Growth Factor (EGF)</td><td>sigma</td><td>E9644</td><td></td></tr><tr><td>Immortalized human renal PTEC (HK2)</td><td></td><td></td><td>courtesey of M. Ryan, university college Dublin</td></tr></tbody></table>

a novel clinical grade isolation method for human kidney perivascular stromal cells

間葉系間質細胞 (MSCs) が恒常性や免疫調節細胞移植や腎臓疾患の有益な効果を示すです。血管周囲間質細胞 (Psc) は、骨髄 MSCs (bmMSCs) の特性を共有します。しかし、彼らも所有している、最も可能性の高いローカル刷り込み、組織固有のプロパティおよびローカル組織の恒常性の役割を果たすのため。ティッシュ特定修理、また、ヒトの腎臓内でこの組織の特異性があります。以前、ひと腎臓 Psc (kPSCs) が腎臓上皮創傷治癒の bmMSCs は、この可能性を持っていなかった一方を強化しました。さらに、kPSCs は、腎臓損傷の生体を改善できます。したがって、kPSCs は、細胞治療、特に腎臓病と腎移植のための興味深いソースを構成します。ここで腎動脈と血管マーカー NG2 の濃縮による消化酵素の全体臓器灌流に基づく人間の腎臓移植グレードから kPSCs の詳細な分離と培養法を示す.この方法では、細胞療法に適している大規模な細胞量を取得できます。

臨床グレード kPSCs 分離法は、図 1のとおりです。原油の腎臓の細胞は、コラゲナーゼ灌流によって人間の移植グレード腎臓から分離されます。結果として得られる細胞懸濁液は 5% 血小板 lysates の合流まで培養しました。その後、血管周囲間質細胞画分は、NG2 式に基づいて分離されます。
kPSCs はプラスチック付着性紡錘形細胞 (図 2A)、CD31 CD34、CD45、HLA-DR (図 2B) 負ながら CD73、CD90, CD105、血管周囲間質マーカー マーカー NG2、試験 B、CD146、陽性です。通常、kPSCs の同質な人口は通路 4 に到達することができ、kPSCs に達する通路 9-10 (図 2C) 周りの老化。したがって、通路 5-8 間実験を実行する勧めします。
分離 kPSCs の機能を評価するため、以前示した kPSCs の馴化培地がこのスクラッチ法15の上皮の創傷治癒過程を加速することが、私たちに kPSCs のすべての新しいバッチに体外腎上皮創傷スクラッチ アッセイを実行します。KPSC 馴化培地 kPSCs alphaMEM 5% 血小板溶解液で 48 時間の培養、培養上清を収集させた。次に、不死化ヒト腎近位尿細管上皮細胞 (HK-2)17合流まで培養し、スクラッチ傷が行われます。どちらか kPSCs またはコントロール中の馴化培地は井戸に追加されます、創傷治癒の速度を測定します。KPSCs の馴化培地を追加すると、傷は格段に速くなります (図 2D) を閉じます。
<img alt="Figure 1" class="xfigimg" src="/files/ftp_upload/55841/55841fig1.jpg"> 
図 1: 臨床等級分離法の人間 kPSCs.移植グレード腎臓を cannulated、腎動脈 (A G) を介してコラゲナーゼと灌流し結果細胞懸濁液を洗浄およびどちらかが凍結したまたは文化 (H ・ K) に入れます。セルに達する confluency (L) と、細胞濃縮は NG2 は (M) を実行しました。どちらかが合流、細胞がトリプシンが増殖または 3 D 構造が (N - P) を表示するときに停止しています。KPSCs のリリース条件は、不妊、マーカー式管状の上皮創傷治癒 (Q) を強化する機能を。矢印: 腎動脈。スケール バー = 200 μ m.<a href="http://ecsource.jove.com/files/ftp_upload/55841/55841fig1large.jpg" target="_blank">この図の拡大版を表示するのにはここをクリックしてください</a>。
<img alt="Figure 2" class="xfigimg" src="/files/ftp_upload/55841/55841fig2.jpg"> 
図 2:特性の人間 kPSCs。) KPSCs、紡錘形、プラスチックの付着性のセル。B) kPSCs は、間葉系マーカー CD73、CD90、CD105、血管マーカー、NG2、試験 β および CD146、CD31 CD34、CD45 陰性間の肯定的です。kPSCs エクスプレス MHC クラス (HLA-ABC) けどクラス II (HLA) ではありません。C) フローサイトメトリーから 3 つの異なる kPSC ドナーの生育特性 (通路 4) で同種の NG2 肯定的な集団を確認します。kPSCs に達する通路 9 10 周り老化。D) kPSCs が傷傷アッセイの腎臓上皮修復を強化することができます。制御媒体と t でエアコン kPSC 媒体の代表的な画像 = 0、4、8、12 h が表示されます。A スケール バー) = 200 μ m、D) = 100 μ m.<a href="http://ecsource.jove.com/files/ftp_upload/55841/55841fig2large.jpg" target="_blank">この図の拡大版を表示するのにはここをクリックしてください</a>。

Watch this Scientific Journal Video about A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells at JoVE.com

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells

腎臓血管周囲間質細胞 (kPSCs) の消化酵素と NG2 細胞濃縮全臓器灌流に基づく新規臨床等級分離と培養法をご紹介します。この方法では、細胞療法の十分なセル番号を取得することが可能です。

ひと腎臓血管周囲間質細胞の新規臨床等級分離法

Mesenchymal Stromal Cells (MSCs) are tissue homeostatic and immune modulatory cells that have shown beneficial effects in kidney diseases and ...

a-novel-clinical-grade-isolation-method-for-human-kidney-perivascular

Research

JoVE Journal

Medicine

6.8K ビュー.  Leiden University Medical Centre. 腎臓血管周囲間質細胞 (kPSCs) の消化酵素と NG2 細胞濃縮全臓器灌流に基づく新規臨床等級分離と培養法をご紹介します。この方法では、細胞療法の十分なセル番号を取得することが可能です。

ビデオ: A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Proteinuria results from the disruption of the glomerular filter that is composed of the fenestrated endothelium, glomerular basement membrane, and podocytes with their slit diaphragms. The delicate structure of the glomerular filter, especially the slit diaphragm, relies on the interplay of diverse cell surface proteins. Studying these cell surface proteins has so far been limited to in vitro studies or histologic analysis. Here, we present a murine in vivo biotinylation labeling method, which enables the study of glomerular cell surface proteins under physiologic and pathophysiologic conditions. This protocol contains information on how to perfuse mouse kidneys, isolate glomeruli, and perform endogenous immunoprecipitation of a protein of interest. Semi-quantitation of glomerular cell surface abundance is readily available with this novel method, and all proteins accessible to biotin perfusion and immunoprecipitation can be studied. In addition, isolation of glomeruli with or without biotinylation enables further analysis of glomerular RNA and protein as well as primary glomerular cell culture (i.e., primary podocyte cell culture).

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Here we present a protocol for murine in vivo labeling of glomerular cell surface proteins with biotin. This protocol contains information on how to perfuse mouse kidneys, isolate glomeruli, and perform endogenous immunoprecipitation of the protein of interest.

腎糸球体と腎糸球体細胞表面タンパク質の標識体内の分離

Proteinuria results from the disruption of the glomerular filter that is composed of the fenestrated endothelium, glomerular basement membrane, and ...

生化学

Isolation of Double Negative &#945;&#946; T Cells from the Kidney

There is currently no standard protocol for the isolation of DN T cells from the non-lymphoid tissues despite their increasingly reported involvement in various immune responses. DN T cells are a unique immune cell type that has been implicated in regulating immune and autoimmune responses and tolerance to allotransplants1-6. DN T cells are, however, rare in peripheral blood and secondary lymphoid organs (spleen and lymph nodes), but are major residents of the normal kidney. Very little is known about their pathophysiologic function7 due to their paucity in the periphery. We recently described a comprehensive phenotypic and functional analysis of this population in the kidney8 in steady state and during ischemia reperfusion injury. Analysis of DN T cell function will be greatly enhanced by developing a protocol for their isolation from the kidney.
Here, we describe a novel protocol that allows isolation of highly pure ab CD4+ CD8+ T cells and DN T cells from the murine kidney. Briefly, we digest kidney tissue using collagenase and isolate kidney mononuclear cells (KMNC) by density gradient. This is followed by two steps to enrich hematopoietic T cells from 3% to 70% from KMNC. The first step consists of a positive selection of hematopoietic cells using a CD45+ isolation kit. In the second step, DN T cells are negatively isolated by removal of non-desired cells using CD4, CD8, and MHC class II monoclonal antibodies and CD1d &#945;-galcer tetramer. This strategy leads to a population of more than 90% pure DN T cells. Surface staining with the above mentioned antibodies followed by FACs analysis is used to confirm purity.

DNabT cells are rare among peripheral T cells; however, they are abundant in certain non-lymphoid tissues. Difficulty of isolating DN T cells from non-lymphoid tissue hinders their functional analysis despite increasing recognized pathophysiologic significance. We describe a novel protocol for isolation of highly purified DN T cells from murine kidney.

腎臓からの二重否定αβT細胞の分離

There is currently no standard protocol for the isolation of DN T cells from the non-lymphoid tissues despite their increasingly reported involvement in ...

免疫・感染学

Reliable and High Efficiency Extraction of Kidney Immune Cells

Immune system activation occurs in multiple kidney diseases and pathophysiological processes. The immune system consists of both adaptive and innate components and multiple cell types. Sometimes, the cell type of interest is present in very low numbers among the large numbers of total cells isolated from the kidney. Hence, reliable and efficient isolation of kidney mononuclear cell populations is important in order to study the immunological problems associated with kidney diseases. Traditionally, tissue isolation of kidney mononuclear cells have been performed via enzymatic digestions using different varieties and strengths of collagenases/DNAses yielding varying numbers of viable immune cells. Recently, with the development of the mechanical tissue disruptors for single cell isolation, the collagenase digestion step is avoided and replaced by a simple mechanical disruption of the kidneys after extraction from the mouse. Herein, we demonstrate a simple yet efficient method for the isolation of kidney mononuclear cells for every day immune cell extractions. We further demonstrate an example of subset analysis of immune cells in the kidney. Importantly, this technique can be adapted to other soft and non-fibrous tissues such as the liver and brain.

Techniques that are reliable and efficient for the isolation of kidney immune cells are needed for downstream applications. This requires surface antibody labeling of a small number of kidney immune cells. Herein, we describe a concise method for isolation of kidney immune cells that seemingly achieves this goal.

腎、免疫細胞の信頼性と高効率抽出

Immune system activation occurs in multiple kidney diseases and pathophysiological processes.  The immune system consists of both adaptive and innate ...

An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney

Preservation of glomerular structure and function is pivotal in the prevention of glomerulonephritis, a category of kidney disease characterized by proteinuria which can eventually lead to chronic and end-stage renal disease. The glomerulus is a complex apparatus responsible for the filtration of plasma from the body. In disease, structural integrity is lost and allows for the abnormal leakage of plasma contents into the urine. A method to isolate and examine glomeruli in culture is critical for the study of these diseases. In this protocol, an efficient method of retrieving intact glomeruli from adult rat kidneys while conserving structural and morphological characteristics is described. This process is capable of generating high yields of glomeruli per kidney with minimal contamination from other nephron segments. With these glomeruli, injury conditions can be mimicked by incubating them with a variety of chemical toxins, including protamine sulfate, which causes foot process effacement and proteinuria in animal models. Degree of injury can be assessed using transmission electron microscopy, immunofluorescence staining, and western blotting. Nephrin and Wilms Tumor 1 (WT1) levels can also be assessed from these cultures. Due to the ease and flexibility of this protocol, the isolated glomeruli can be utilized as described or in a way that best suits the needs of the researcher to help better study glomerular health and structure in diseased states.

The main focus of this protocol is to efficiently isolate viable primary glomeruli cultures with minimal contaminants for use in a variety of downstream applications. The isolated glomeruli retain structural relationships between component cell types and can be cultured ex vivo for a short time.

ラット腎臓からそのまま糸球体を分離する効率的なふるい分け法

Preservation of glomerular structure and function is pivotal in the prevention of glomerulonephritis, a category of kidney disease characterized by ...

医学

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Podocytes (renal glomerular epithelial cells) are known to regulate glomerular permeability and maintain glomerular structure; a key role for these cells in the pathogenesis of various renal diseases has been established since podocyte injury leads to proteinuria and foot process effacement. It was previously reported that various endogenous agents may cause a dramatic overload in intracellular Ca2+ concentration in podocytes, presumably leading to albuminuria, and this likely occurs via calcium-conducting ion channels. Therefore, it appeared important to study calcium handling in the podocytes both under normal conditions and in various pathological states. However, available experimental approaches have remained somewhat limited to cultured and transfected cells. Although they represent a good basic model for such studies, they are essentially extracted from the native environment of the glomerulus. Here we describe the methodology of studying podocytes as a part of the freshly isolated whole glomerulus. This preparation retains the functional potential of the podocytes, which are still attached to the capillaries; therefore, podocytes remain in the environment that conserves the major parts of the glomeruli filtration apparatus. The present manuscript elaborates on two experimental approaches that allow 1) real-time detection of calcium concentration changes with the help of ratiometric confocal fluorescence microscopy, and 2) the recording of the single ion channels activity in the podocytes of the freshly isolated glomeruli. These methodologies utilize the advantages of the native environment of the glomerulus that enable researchers to resolve acute changes in the intracellular calcium handling in response to applications of various agents, measure basal concentration of calcium within the cells (for instance, to evaluate disease progression), and assess and manipulate calcium conductance at the level of single ion channels.

Changes in the intracellular calcium levels in the podocytes are one of the most important means to control the filtration function of glomeruli. Here we explain a high-throughput approach that allows detection of real-time calcium handling and single ion channels activity in the podocytes of the freshly isolated glomeruli.

新たに単離した糸球体の足細胞における単一チャネル分析とカルシウムイメージング

Podocytes (renal glomerular epithelial cells) are known to regulate glomerular permeability and maintain glomerular structure; a key role for these cells ...

生物学

Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells

Mitochondrial dysfunction in the renal tubular epithelial cells (TECs) can lead to renal fibrosis, a major cause of&#160;chronic kidney disease (CKD). Therefore, assessing mitochondrial function in primary TECs may provide valuable insight into the bioenergetic status of the cells, providing insight into the pathophysiology of CKD. While there are a number of complex protocols available for the isolation and purification of proximal tubules in different species, the field lacks a cost-effective method optimized for&#160;tubular cell isolation without the need for purification. Here, we provide an isolation protocol that allows for studies focusing on both primary mouse proximal and distal renal TECs. In addition to cost-effective reagents and minimal animal procedures required in this protocol, the isolated cells maintain high energy levels after isolation and can be sub-cultured up to four&#160;passages, allowing for continuous studies. Furthermore, using a high throughput extracellular flux analyzer, we assess the mitochondrial respiration directly in the isolated TECs in a 96-well plate for which we provide recommendations for the optimization of cell density and compound concentration. These observations suggest that this protocol can be used for renal tubular ex vivo studies with a consistent, well-standardized production of renal TECs. This protocol may have broader future applications to study mitochondrial dysfunction associated with renal disorders for drug discovery or drug characterization purposes.

This protocol provides a cost-effective approach to isolate and characterize mouse primary renal tubular cells that can subsequently be sub-cultured to assess renal biological functions ex vivo, including mitochondrial bioenergetics.

マウスの主な腎尿細管上皮細胞の分離と性質、高スループットの細胞フラックスの解析

Mitochondrial dysfunction in the renal tubular epithelial cells (TECs) can lead to renal fibrosis, a major cause of&#160;chronic kidney disease (CKD). ...

Isolation of Conditionally Immortalized Mouse Glomerular Endothelial Cells with Fluorescent Mitochondria

Glomerular endothelial cell (GEC) dysfunction can initiate and contribute to glomerular filtration barrier breakdown. Increased mitochondrial oxidative stress has been suggested as a mechanism resulting in GEC dysfunction in the pathogenesis of some glomerular diseases. Historically the isolation of GECs from in vivo models has been notoriously challenging due to difficulties in isolating pure cultures from glomeruli. GECs have complex growth requirements in vitro and a very limited lifespan. Here, we describe the procedure for isolating and culturing conditionally immortalized GECs with fluorescent mitochondria, enabling the tracking of mitochondrial fission and fusion events. GECs were isolated from the kidneys of a double transgenic mouse expressing the thermolabile SV40 TAg (from the Immortomouse), conditionally promoting proliferation and suppressing cell differentiation, and a photo-convertible fluorescent protein (Dendra2) in all mitochondria (from the photo-activatable mitochondria [PhAMexcised] mouse). The stable cell line generated allows for cell differentiation after inactivation of the immortalizing SV40 TAg gene and photo-activation of a subset of mitochondria causing a switch in fluorescence from green to red. The use of mitoDendra2-GECs allows for live imaging of fluorescent mitochondria&#39;s distribution, fusion, and fission events without staining the cells.

The article describes the method for isolating conditionally immortalized glomerular endothelial cells from the kidneys of transgenic mice expressing the thermolabile simian virus 40 and photo-activatable mitochondria, PhAMexcised. We describe the procedure for glomeruli isolation from whole kidneys using beads, digestion steps, seeding, and culturing of GECs-CD31 positive.

蛍光ミトコンドリアによる条件付き不死化マウス糸球体内皮細胞の単離

Glomerular endothelial cell (GEC) dysfunction can initiate and contribute to glomerular filtration barrier breakdown. Increased mitochondrial oxidative ...

Isolation of Primary Human Proximal Tubule Epithelial Cells and Their Use in Creating a Microphysiological Model of the Renal Proximal Tubule

Kidney disease affects over 850 million people globally, including 37 million Americans. Risk factors for&#160;chronic kidney disease include environmental influences, genetic predispositions, co-existing medical conditions, and a history of acute kidney injury. These factors often take months or years to develop, complicating longitudinal studies of disease etiology and pathophysiology. Advanced kidney models are needed to improve our understanding of disease mechanisms and enhance nephrotoxicity prediction in drug development. Proximal tubule epithelial cells (PTECs) in the kidney play a critical role in xenobiotic and toxin clearance as well as the reabsorption of essential nutrients. We have previously demonstrated that three-dimensional (3D) microphysiological system (MPS) platforms, populated with isolated primary PTECs, can be used to investigate renal drug interactions, assess nephrotoxicity of compounds, and predict drug clearance. Here, we present protocols for isolating and culturing primary PTECs from whole human kidneys and for seeding them into a 3D MPS platform that mimics in vivo renal physiology. This protocol enables long-term studies supporting PTEC viability, physiological morphology, and functional polarization of key transporter proteins in MPS devices for up to 6 months.

We present an optimized protocol for processing whole human kidneys to isolate and culture primary renal proximal tubule epithelial cells and the application of these cells in a three-dimensional, microfluidic, microphysiological platform to recapitulate the renal proximal tubule.

初代ヒト近位尿細管上皮細胞の単離と腎近位尿細管の微生理学的モデルの作成におけるそれらの使用

Kidney disease affects over 850 million people globally, including 37 million Americans. Risk factors for&#160;chronic kidney disease include ...

Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells

Mesangial cells (MCs) are stromal cells located in the middle space of the glomerulus, with pivotal functions in glomerular homeostasis. Methods for isolating, purifying, and culturing glomerular MCs have been developed and optimized since the 1980s for use in biomedical research, particularly in the field of nephrology. Mice are the most frequently used experimental animal models in research on renal diseases. In this study, we developed an optimized protocol for murine MCs isolation and ex vivo cell culture. These cells can be passaged multiple times, frozen, revived, and cultured without compromising cell growth or protein expression. This optimized approach significantly reduces the study duration for researchers and enables long-term cell preservation. The necessary equipment for the procedures is easily accessible in a basic biomedical laboratory, and the procedural steps are straightforward. The acquisition of target cells requires only 2-3 weeks, a reduction of at least 1 week compared to existing methods.

This study developed an optimized protocol for the isolation of murine mesangial cells (MCs) and their ex vivo cell culture. These cells can be passaged multiple times, frozen, revived, and cultured without compromising cell growth or protein expression.

マウス糸球体メサンギウム細胞の単離と精製の最適化

Mesangial cells (MCs) are stromal cells located in the middle space of the glomerulus, with pivotal functions in glomerular homeostasis. Methods for ...

Murine Renal Cell Isolation: A Technique to Isolate and Generate Primary Culture of Renal Tubular Epithelial Cells

Source: Ding, W. et al. <a href="https://www.jove.com/video/57718" target="_blank">Isolation, Characterization and High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells.</a> J. Vis. Exp. (2018)
In this video, we demonstrate the steps to isolate and purify renal tubular epithelial cells for a wide range of molecular biology and cell culture studies.

マウス腎細胞単離:腎尿細管上皮細胞の初代培養を単離および作製する技術

Source: Ding, W. et al. Isolation, Characterization and High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells. J. ...